Genelux (GNLX) News Today $2.50 -0.04 (-1.38%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Genelux's (GNLX) "Buy" Rating Reiterated at HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $30.00 price objective on shares of Genelux in a research report on Monday.April 1 at 8:19 AM | marketbeat.comGenelux (NASDAQ:GNLX) Given "Buy" Rating at HC WainwrightApril 1 at 2:23 AM | americanbankingnews.comBrookline Capital Management Predicts Genelux FY2024 EarningsMarch 30, 2025 | americanbankingnews.comGenelux (NASDAQ:GNLX) Releases Earnings Results, Misses Expectations By $0.07 EPSGenelux (NASDAQ:GNLX - Get Free Report) released its quarterly earnings data on Friday. The company reported ($0.26) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.19) by ($0.07).March 29, 2025 | marketbeat.comResearch Analysts Set Expectations for Genelux FY2024 EarningsGenelux Co. (NASDAQ:GNLX - Free Report) - Equities research analysts at Brookline Capital Management issued their FY2024 EPS estimates for shares of Genelux in a research report issued on Tuesday, March 25th. Brookline Capital Management analyst K. Dolliver anticipates that the company will postMarch 29, 2025 | marketbeat.comGenelux reports FY24 EPS (95c), consensus (88c)March 29, 2025 | markets.businessinsider.comGenelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateMarch 28, 2025 | globenewswire.comEquities Analysts Issue Forecasts for Genelux Q1 EarningsGenelux Co. (NASDAQ:GNLX - Free Report) - Equities researchers at Brookline Capital Management issued their Q1 2025 earnings estimates for Genelux in a report issued on Tuesday, March 25th. Brookline Capital Management analyst K. Dolliver forecasts that the company will earn ($0.20) per share forMarch 28, 2025 | marketbeat.comFY2024 EPS Estimates for Genelux Lifted by HC WainwrightGenelux Co. (NASDAQ:GNLX - Free Report) - Equities research analysts at HC Wainwright upped their FY2024 earnings per share (EPS) estimates for Genelux in a note issued to investors on Tuesday, March 25th. HC Wainwright analyst E. Bodnar now anticipates that the company will earn ($0.84) per sharMarch 28, 2025 | marketbeat.comFY2024 Earnings Estimate for Genelux Issued By HC WainwrightMarch 28, 2025 | americanbankingnews.comBrookline Capital Management Forecasts Genelux Q1 EarningsMarch 28, 2025 | americanbankingnews.comGenelux (GNLX) Projected to Post Quarterly Earnings on FridayGenelux (NASDAQ:GNLX) will be releasing earnings before the market opens on Friday, April 4, Financial Modeling Prep reports.March 28, 2025 | marketbeat.comResearch Analysts Offer Predictions for Genelux Q1 EarningsGenelux Co. (NASDAQ:GNLX - Free Report) - Equities research analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for Genelux in a research note issued on Tuesday, March 25th. HC Wainwright analyst E. Bodnar forecasts that the company will post earnings per share of ($0.16)March 27, 2025 | marketbeat.comGenelux (NASDAQ:GNLX) Receives Buy Rating from HC WainwrightMarch 27, 2025 | americanbankingnews.comGenelux announces alignment with FDA of approval pathway for Olvi-VecMarch 26, 2025 | markets.businessinsider.comGenelux's (GNLX) Buy Rating Reiterated at HC WainwrightHC Wainwright restated a "buy" rating and issued a $30.00 price target on shares of Genelux in a research report on Tuesday.March 26, 2025 | marketbeat.comGenelux, Newsoara announce preliminary Phase 1b/2 data of Olvi-VecMarch 26, 2025 | markets.businessinsider.comGenelux Corporation: Genelux and Newsoara Announce Positive Preliminary Phase 1b/2 Data of Olvi-Vec in Advanced Small-Cell Lung CancerMarch 25, 2025 | finanznachrichten.deGenelux Announces Alignment with FDA on Key Elements of the Approval Pathway for Olvi-Vec in Platinum Resistant/Refractory DiseaseMarch 25, 2025 | markets.businessinsider.comGenelux Corporation Announces Pricing of $10.5 Million Underwritten Offering of Common StockMarch 25, 2025 | globenewswire.comGenelux (NASDAQ:GNLX) Stock Price Down 1.3% - Here's What HappenedGenelux (NASDAQ:GNLX) Shares Down 1.3% - What's Next?March 22, 2025 | marketbeat.comWhy Genelux Corporation (GNLX) is Skyrocketing So Far in 2025March 2, 2025 | msn.comOne new option listing on February 19thFebruary 19, 2025 | markets.businessinsider.comGenelux Co. (NASDAQ:GNLX) Stock Position Decreased by Woodward Diversified Capital LLCWoodward Diversified Capital LLC decreased its stake in shares of Genelux Co. (NASDAQ:GNLX - Free Report) by 5.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,268,305 shares of the company's stock after selling 75,February 8, 2025 | marketbeat.comGenelux Brings in Arrowhead Pharmaceuticals Exec as New Finance ChiefFebruary 3, 2025 | marketwatch.comGenelux appoints new CFO as Lourie Zak departsFebruary 3, 2025 | msn.comGenelux appoints new CFO amid clinical advancementsFebruary 3, 2025 | msn.comGenelux Appoints Matthew Pulisic As CFO, Stock DropsFebruary 3, 2025 | markets.businessinsider.comGenelux Corporation Announces New Chief Financial OfficerFebruary 3, 2025 | globenewswire.comWe Think Genelux (NASDAQ:GNLX) Needs To Drive Business Growth CarefullyJanuary 24, 2025 | finance.yahoo.comGenelux Corporation to Participate in a Fireside Chat with H.C. WainwrightDecember 13, 2024 | globenewswire.comGenelux Corp’s Strategic Advances in Cancer Trials Position GNLX as a Promising InvestmentNovember 17, 2024 | markets.businessinsider.comThese 2 “Strong Buy” Penny Stocks Are Set to Triple (or more), Say AnalystsNovember 15, 2024 | finance.yahoo.comGenelux (NASDAQ:GNLX) Price Target Cut to $30.00 by Analysts at HC WainwrightHC Wainwright cut their price target on Genelux from $32.00 to $30.00 and set a "buy" rating on the stock in a research report on Friday.November 15, 2024 | marketbeat.comGenelux Corporation Reports Third Quarter 2024 Financial Results and Provides General Business UpdatesNovember 14, 2024 | markets.businessinsider.comGenelux Corp. Releases New Corporate PresentationNovember 9, 2024 | markets.businessinsider.comGenelux Corporation to Participate in Fireside Chat at the Guggenheim Inaugural Healthcare Innovation ConferenceNovember 6, 2024 | globenewswire.comIndividual investors who hold 56% of Genelux Corporation (NASDAQ:GNLX) gained 34%, institutions profited as wellOctober 31, 2024 | finance.yahoo.comGenelux initiated with a Buy at GuggenheimOctober 30, 2024 | markets.businessinsider.comGuggenheim Initiates Coverage of Genelux (GNLX) with Buy RecommendationOctober 30, 2024 | msn.comGenelux Co. (NASDAQ:GNLX) Receives Consensus Rating of "Buy" from BrokeragesShares of Genelux Co. (NASDAQ:GNLX - Get Free Report) have been given an average rating of "Buy" by the five analysts that are covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the coOctober 29, 2024 | marketbeat.comGenelux (NASDAQ:GNLX) Now Covered by GuggenheimGuggenheim began coverage on shares of Genelux in a research note on Tuesday. They issued a "buy" rating and a $8.00 target price for the company.October 29, 2024 | marketbeat.comHighbridge Capital Management LLC Acquires Significant Stake in Genelux CorpOctober 25, 2024 | finance.yahoo.comPromising Growth Potential and Clinical Advancements Drive Buy Rating for Genelux Corp.October 25, 2024 | markets.businessinsider.comGenelux doses first subject in Phase II trial of NSCLC treatmentOctober 23, 2024 | finance.yahoo.comGenelux:1st patient dosed in VIRO-25 trial with Olvi-Vec in NSCLCOctober 23, 2024 | markets.businessinsider.comGenelux (NASDAQ:GNLX) Stock Quotes, Forecast and News SummaryOctober 23, 2024 | benzinga.comGenelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung CancerOctober 22, 2024 | globenewswire.comGenelux Corporation to Participate in the 2024 Maxim Healthcare Virtual SummitOctober 9, 2024 | globenewswire.com900,000 Shares in Genelux Co. (NASDAQ:GNLX) Acquired by Armistice Capital LLCArmistice Capital LLC acquired a new stake in Genelux Co. (NASDAQ:GNLX - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 900,000 shares of the company's stock, valued at approximately $1,755,September 27, 2024 | marketbeat.com Remove Ads Get Genelux News Delivered to You Automatically Sign up to receive the latest news and ratings for GNLX and its competitors with MarketBeat's FREE daily newsletter. Email Address GNLX Media Mentions By Week GNLX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GNLX News Sentiment▼0.650.57▲Average Medical News Sentiment GNLX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GNLX Articles This Week▼242▲GNLX Articles Average Week Remove Ads Get Genelux News Delivered to You Automatically Sign up to receive the latest news and ratings for GNLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Precigen News Relay Therapeutics News Opthea News ORIC Pharmaceuticals News Mind Medicine (MindMed) News Maze Therapeutics News Sionna Therapeutics News Verve Therapeutics News Sage Therapeutics News Cullinan Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GNLX) was last updated on 4/3/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genelux Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genelux With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
